My pick for today:
Ipsen and Inspiration Biopharmaceuticals, Inc. announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency has issued a positive opinion on the granting of orphan drug status for OBI-1 for the treatment of hemophilia. original. Site of qtpandayert
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment